Jakub Tolar, MD, PhD
Jakub Tolar, MD, PhD, dean of the Medical School and interim vice president for health sciences of the Academic Health Center, is at the forefront of blood and marrow transplantation for bone marrow failure and metabolic disorders. His research focuses on the use of bone marrow derived stem cells for correcting genetic diseases and improving the outcomes for blood and marrow transplant patients. Tolar’s research is also investigating novel gene and cellular therapy for organs, such as heart, brain and bone, that are resistant to correction with bone marrow transplantation. Most recently, he was recognized for his work in using a blood and marrow transplant of stem cells to treat severe forms of a rare skin disease called epidermolysis bullosa, or EB. Tolar is a member of the Masonic Cancer Center’s Transplant Biology and Therapy Research Program.